Este es un espacio para difundir las publicaciones científicas de nuestros/as socios/as.
The host Rab9a/ Rab32 axis is actively recruited to the T. cruzi parasitophorous vacuole and benefits the infection cycle. Betiana Nebaí Salassa, Juan Agustín Cueto, María Cristina Vanrell, María Belén López, Albert Descoteaux, Carlos Alberto Labriola, Patricia Silvia Romano.
Molecular Microbiology, 10.1111/mmi.15217. 9 Jan. 2024, doi:10.1111/mmi.15217
Triclabendazole and clofazimine reduce replication and spermine uptake in vitro in Toxoplasma gondii. Maria M. Corvi, Franco Rossi, Agustina Ganuza, Andrés M. Alonso, Lucas N. Alberca, Roque C. Dietrich, Luciana Gavernet, Alan Talevi
Parasitology Research (2024) 123:69 doi: 10.1007/s00436-023-08062-4
The Trypanosoma cruzi Antigen and Epitope Atlas: antibody specificities in Chagas disease patients across the Americas. Alejandro D. Ricci, Leonel Bracco, Emir Salas-Sarduy, Janine M. Ramsey, Melissa S. Nolan, M. Katie Lynn, Jaime Altcheh, Griselda E. Ballering, Faustino Torrico, Norival Kesper, Juan C. Villar, Iván S. Marcipar, Jorge D. Marco & Fernán Agüero
Nature Communications 14, 1850 (2023) doi.org/10.1038/s41467-023-37522-9
Combination of ultra-rapid DNA purification (PURE) and loop-mediated isothermal amplification (LAMP) for rapid detection of Trypanosoma cruzi DNA in dried blood spots. Silvia A Longhi, Lady J García Casares, Arturo A Muñoz-Calderón, Julio Alonso-Padilla, Alejandro G Schijman.
PLoS neglected tropical diseases vol. 17,4 e0011290. 14 Apr. 2023, doi:10.1371/journal.pntd.0011290.
The Exosome-like Vesicles of Giardia Assemblages A, B, and E: Are Involved in the Delivering of Distinct Small RNA from Parasite to Parasite
Lautaro Natali,Gabriel Luna Pizarro, Sofía Moyano, Benjamin de la Cruz-Thea, Juliana Musso, Andrea S. Rópolo, Norbert Eichner , Gunter Meister , Melina M. Musri, Constanza Feliziani and María C. Touz.
Int. J. Mol. Sci. 2023, 24, 9559. https://doi.org/10.3390/ ijms24119559
Activation-induced marker assays for identification of Trypanosoma cruzi-specific CD4 or CD8 T cells in chronic Chagas disease patients. Fátima Ferragut, Karen M Cruz, Juan P Gallardo, Marisa Fernández, Yolanda Hernández Vasquez, Karina A Gómez
Immunology. 2022 Dec 25. doi: 10.1111/imm.13622
Broadening the spectrum of ivermectin: its effects on Trypanosoma cruzi and related trypanosomatids.
L. Fraccaroli, MD Ruiz, VG Perdomo, AN Clausi, DE Balcazar, L Larocca y C Carrillo.
Front cell Infect Microbiol. 2022; 12:885268
doi: 10,3389/fcimb.2022,885268
Cruzipain Sulfotopes-Specific Antibodies Generate Cardiac Tissue Abnormalities and Favor Trypanosoma cruzi Infection in the BALB/c Mice Model of Experimental Chagas Disease. Luciana L. Soprano, Maximiliano R. Ferrero , Malena Landoni, Gabriela A. García, Mónica I. Esteva , Alicia S. Couto and Vilma G. Duschak
Front Cell Infect Microbiol. 2022;11:814276. doi: 10.3389/fcimb.2021.814276
Prospective multicenter evaluation of real time PCR Kit prototype for early diagnosis of congenital Chagas disease. Alejandro F Benatar, Emmaría Danesi, Susana A Besuschio, Santiago Bortolotti, María L Cafferata, Juan C Ramirez, Constanza Lopez Albizu, Karenina Scollo, María Baleani, Laura Lara, Gustavo Agolti, Sandra Seu, Elsa Adamo, Raúl H Lucero, Lucía Irazu, Marcelo Rodriguez, Andrés Poeylaut-Palena, Silvia A Longhi, Mónica Esteva, Fernando Althabe, Federico Rojkin, Jacqueline Bua, Sergio Sosa-Estani , Alejandro G Schijman; Congenital Chagas Disease Study Group
EBioMedicine vol. 69 (2021): 103450. doi:10.1016/j.ebiom.2021.103450